新的三维生物活性增强填充剂用于改善生物医学聚合物的特性:合成和应用
Mehdi Sadat-Shojai1, Mohammad Kalantari-Lalari1, Milad Asadnia1
1Department of Chemistry, College of Sciences, Shiraz University, Shiraz 71454, Iran.
ACS omega
|January 22, 2024
概括
填充物几何学显著影响生物医学聚合物复合材料. 花样酸 (3D DHA) 填充剂增强了聚3-酸-co-3-酸 (PHBV) 的强度和生物特性.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物科学 聚合物科学
- 材料工程 材料工程 材料工程
背景情况:
- 复合材料的增强效率取决于填充剂的特性.
- 研究往往侧重于填充剂的百分比和粘合,忽视了填充剂几何学的作用.
- 了解填充物几何学的影响对于先进的生物医学聚合物应用至关重要.
研究的目的:
- 调查三维 (3D) 生物活性填充物几何学对生物医学聚合物的机械和生物增强的影响.
- 为了合成和表征 dandelion-like hydroxyapatite (DHA) 作为一个3D生物活性填充剂.
- 为了评估由表面修饰的DHA制成的复合材料的性能,在一个多3-基酸-co-3-基酸) (PHBV) 矩阵中.
主要方法:
- 通过水热方法合成非常规的英类酸 (DHA).
- 用西兰分子对DHA颗粒表面进行修改.
- 使用溶液造和机械和生物特性评估制造PHBV/DHA复合材料.
主要成果:
- 与整洁的PHBV和带有不规则填充剂的复合材料相比,表面修改3D DHA的复合材料显著提高了拉伸强度和弹性模量.
- 3D DHA填充剂对PHBV的水浸透性,生物降解性和生物活性产生了积极的影响.
- 在含有3D DHA填充剂的复合材料中,体外细胞反应显著增强.
结论:
- 填充物几何是影响生物医学聚合物复合材料机械和生物性能的关键因素.
- 表面修饰的3D DHA颗粒为生物医学应用增强PHBV特性提供了一个有前途的策略.
- 该研究强调了粒子几何学在设计高性能生物材料中的低估作用.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


